Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
MIGMA uses Artificial Intelligence to accelerate the discovery of new synergistic combinations of antioxidants.
Next-gen gut health delivery using bacterial vesicles for precise, effective, and cost-efficient supplement delivery.
Pioneering novel antibody-based cancer therapies informed by large-scale patient-derived biology.
BioPlaster Research seeks the development of science and technology for the care of the environment and the proliferation of nanotechnology.
EYWA designs the best processes and products to boost the adoption of psychedelic medicine, harnessing the power of biosynthesis.
Monte Caldera is a data-driven scientific firm that offers consulting and molecular-level simulation services to a wide array of industries.
Insecticides inspired by arachnid venom
Cell rejuvenation with small molecules — no gene editing required. Starting with cancer, extending to longevity.
UpDairy is a food tech startup company that develops alternative dairy proteins through precision fermentation.
Bioeutectics is revolutionising the solvent industry, turning it into one that is natural and biodegradable.
Aquit develops preventive treatments for infections in fish that replace antibiotics, improve survival rates, and boost natural immunity.
Transforming ingredients into high-performance bio-nanoparticles with over 15% enhanced bioavailability to redefine nutrition and longevity.
CyanoMin harnesses cyanobacteria to make carbon-negative minerals without mining, reducing the net carbon footprint of the products.
Elytron is an innovative approach to the production of biopesticides.
Fecundis develops technologies that enhance sperm functionality, resulting in the generation of more and better embryos.
Gisens Biotech provides bioelectronics and nanotechnology services.
Bioplastix aims to produce biomaterials with outstanding properties, derived from renewable sources at competitive prices.
Nanogrow Biotech is a manufacturer of nano antibiotics with the goal of developing novel applications in the pharmaceutical industry.
We offer an on-site organic waste management service which uses our insect-based biotechnolgy platform to create high value-added products.
Invitrall develops advanced diseases in vitro models that represent human genetic diversity that provides innovative solutions.
Food4You is a biotech platform that offers natural ingredients for plant-based food.
Oral vaccines for farmed animals. Vaccination simple and hassle free.
Last mile Hydrogen Generation for Industrial Processes Decarbonization
Organic coatings that protect produce from spoilage and decay.
GRID EXPONENTIAL has invested in 51 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
GRID EXPONENTIAL's top investment sectors include Biotechnology, Food and Beverage, Health Care, Advanced Materials, Life Science. The firm invests across 38 different industry categories.
Among tracked funding rounds, OncoPrecision received $4.5M in a Seed round. GRID EXPONENTIAL's total known invested capital is $33.2M.
GRID EXPONENTIAL's average investment size is $651K across its portfolio of 51 companies.
Recent GRID EXPONENTIAL portfolio additions include MIGMA, BioClé, OncoPrecision, BioPlaster Research, EYWA. These companies were founded in 2020 or later.